Is PSA doubling time reliable as a progression risk criterion for patients with low-risk prostate cancer in an active surveillance programme?

Frederik Birkebæk Thomsen; Ib Jarle Christensen; Martin Andreas Røder; Klaus Brasso; Peter Iversen

Is PSA doubling time reliable as a progression risk criterion for patients with low-risk prostate cancer in an active surveillance programme?

Frederik Birkebæk Thomsen, Ib Jarle Christensen, Martin Andreas Røder, Klaus Brasso, Peter Iversen

Original language	English
Journal	European Urology Supplements
Volume	12
Issue number	1
Pages (from-to)	e273-e274
Number of pages	1
ISSN	1569-9056
Publication status	Published - 2013
Event	28th Annual Congress, European Association of Urology - Milan, Italy Duration: 15 Mar 2013 → 19 Mar 2013 Conference number: 28

Conference

Conference	28th Annual Congress, European Association of Urology
Number	28
Country/Territory	Italy
City	Milan
Period	15/03/2013 → 19/03/2013

Cite this

Is PSA doubling time reliable as a progression risk criterion for patients with low-risk prostate cancer in an active surveillance programme? / Thomsen, Frederik Birkebæk; Christensen, Ib Jarle ; Røder, Martin Andreas et al.
In: European Urology Supplements, Vol. 12, No. 1, 2013, p. e273-e274.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

@article{83dde478a453429aba9f5b8a258ff84c,

title = "Is PSA doubling time reliable as a progression risk criterion for patients with low-risk prostate cancer in an active surveillance programme?",

author = "Thomsen, {Frederik Birkeb{\ae}k} and Christensen, {Ib Jarle} and R{\o}der, {Martin Andreas} and Klaus Brasso and Peter Iversen",

year = "2013",

language = "English",

volume = "12",

pages = "e273--e274",

journal = "European Urology Supplements",

issn = "1569-9056",

publisher = "Elsevier BV",

number = "1",

note = "28th Annual Congress, European Association of Urology ; Conference date: 15-03-2013 Through 19-03-2013",